S L Zettervall1, P A Soden2, S E Deery2, K Ultee3, K E Shean2, F Shuja2, R L Amdur4, M L Schermerhorn5. 1. Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA; Department of Surgery, George Washington University, Washington, DC, USA. 2. Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA. 3. Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA; Erasmus University Medical Center, Rotterdam, The Netherlands. 4. Department of Surgery, George Washington University, Washington, DC, USA. 5. Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA. Electronic address: mscherm@bidmc.harvard.edu.
Abstract
OBJECTIVES: Surgeons have multiple grafts options available for the endovascular treatment of abdominal aortic aneurysm (EVAR), and some hypothesize that suprarenal fixation endografts may result in higher rates of renal complications than infrarenal endografts. This study aimed to compare the outcomes of contemporary suprarenal and infrarenal endografts. METHODS: The Targeted Vascular Module of the National Surgical Quality Improvement Project was utilised to identify patients undergoing EVAR for infrarenal aneurysm from 2011 to 2013. Pre-operative and operative variables and 30 day outcomes were compared among suprarenal (Zenith and Endurant) and infrarenal fixation devices (Excluder). Renal complications included creatinine increase > 2 mg/dL or new dialysis, as defined by NSQIP. Multivariate regression was completed to account for patient demographics, comorbidities, and operative characteristics. RESULTS: A total of 3587 patients were evaluated including 2273 (63%) with suprarenal grafts and 1314 (37%) with infrarenal grafts. Patients with suprarenal grafts were less commonly white (84% vs. 88%, p < .01) and more commonly male (83% vs. 80%, p = .03). There were no differences in age or comorbidities. Renal complications (1.1% vs. 0.1%, p < .01) and length of stay more than 2 days (34% vs. 25%, p < .01) occurred more commonly after suprarenal fixation. After adjustment, suprarenal grafts had significantly higher rates of renal complications (OR, 12.0; 95% CI, 1.6-91) and length of stay more than 2 days (OR, 1.4; 95% CI, 1.2-1.7). CONCLUSION: Overall rates of renal complications following EVAR are low. Patients selected for suprarenal stent grafts are at increased risk of renal complications and prolonged length of stay, which may be due to selection bias, deployment techniques, or the presence of a bare stent overlying the renal arteries. Further studies are necessary to evaluate the mechanism and duration of renal dysfunction and important long-term outcomes of interest.
OBJECTIVES: Surgeons have multiple grafts options available for the endovascular treatment of abdominal aortic aneurysm (EVAR), and some hypothesize that suprarenal fixation endografts may result in higher rates of renal complications than infrarenal endografts. This study aimed to compare the outcomes of contemporary suprarenal and infrarenal endografts. METHODS: The Targeted Vascular Module of the National Surgical Quality Improvement Project was utilised to identify patients undergoing EVAR for infrarenal aneurysm from 2011 to 2013. Pre-operative and operative variables and 30 day outcomes were compared among suprarenal (Zenith and Endurant) and infrarenal fixation devices (Excluder). Renal complications included creatinine increase > 2 mg/dL or new dialysis, as defined by NSQIP. Multivariate regression was completed to account for patient demographics, comorbidities, and operative characteristics. RESULTS: A total of 3587 patients were evaluated including 2273 (63%) with suprarenal grafts and 1314 (37%) with infrarenal grafts. Patients with suprarenal grafts were less commonly white (84% vs. 88%, p < .01) and more commonly male (83% vs. 80%, p = .03). There were no differences in age or comorbidities. Renal complications (1.1% vs. 0.1%, p < .01) and length of stay more than 2 days (34% vs. 25%, p < .01) occurred more commonly after suprarenal fixation. After adjustment, suprarenal grafts had significantly higher rates of renal complications (OR, 12.0; 95% CI, 1.6-91) and length of stay more than 2 days (OR, 1.4; 95% CI, 1.2-1.7). CONCLUSION: Overall rates of renal complications following EVAR are low. Patients selected for suprarenal stent grafts are at increased risk of renal complications and prolonged length of stay, which may be due to selection bias, deployment techniques, or the presence of a bare stent overlying the renal arteries. Further studies are necessary to evaluate the mechanism and duration of renal dysfunction and important long-term outcomes of interest.
Authors: Ali F AbuRahma; John Campbell; Patrick A Stone; Aravinda Nanjundappa; Akhilesh Jain; L Scott Dean; Joseph Habib; Tammi Keiffer; Mary Emmett Journal: J Vasc Surg Date: 2009-10 Impact factor: 4.268
Authors: Ronald M Fairman; Omaida C Velazquez; Jeffrey P Carpenter; Edward Woo; Richard A Baum; Michael A Golden; Boonprasit Kritpracha; Frank Criado Journal: J Vasc Surg Date: 2004-12 Impact factor: 4.268
Authors: Gregory G Salzler; Andrew J Meltzer; Jialin Mao; Abby Isaacs; Peter H Connolly; Darren B Schneider; Art Sedrakyan Journal: J Vasc Surg Date: 2015-08-05 Impact factor: 4.268
Authors: Dominique B Buck; Peter A Soden; Sarah E Deery; Sara L Zettervall; Klaas H J Ultee; Bruce E Landon; A James O'Malley; Marc L Schermerhorn Journal: Ann Vasc Surg Date: 2017-09-08 Impact factor: 1.466
Authors: Maaike A Koenrades; Almar Klein; Anne M Leferink; Cornelis H Slump; Robert H Geelkerken Journal: J Endovasc Ther Date: 2018-04-30 Impact factor: 3.487
Authors: Choi Sangtae; Lee Wonsuk; Kang Jinmo; Kim Doojin; Ko Daisik Journal: Turk Gogus Kalp Damar Cerrahisi Derg Date: 2021-10-20 Impact factor: 0.332
Authors: Alexander Geragotellis; Kofi Cox; Ho Cheung Anthony Yip; Matti Jubouri; Ian M Williams; Damian M Bailey; Mohamad Bashir Journal: Cardiovasc Diagn Ther Date: 2022-08